X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1864) 1864
Publication (236) 236
Book Chapter (40) 40
Book Review (34) 34
Book / eBook (10) 10
Conference Proceeding (3) 3
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1309) 1309
index medicus (1058) 1058
oncology (760) 760
cancer (570) 570
male (551) 551
female (550) 550
middle aged (431) 431
metastasis (404) 404
aged (391) 391
tumors (333) 333
adult (322) 322
chemotherapy (319) 319
metastatic colorectal-cancer (264) 264
animals (243) 243
medicine & public health (238) 238
surgery (232) 232
prognosis (226) 226
care and treatment (219) 219
pathology (219) 219
metastatic breast-cancer (212) 212
neuroendocrine tumors (209) 209
treatment outcome (203) 203
diagnosis (192) 192
survival (189) 189
research (188) 188
antineoplastic agents - therapeutic use (173) 173
immunohistochemistry (173) 173
aged, 80 and over (169) 169
neoplasms - drug therapy (163) 163
health aspects (158) 158
carcinoma (148) 148
radiology, nuclear medicine & medical imaging (144) 144
management (138) 138
pharmacology & pharmacy (137) 137
metastases (136) 136
analysis (135) 135
retrospective studies (133) 133
cell lung-cancer (129) 129
neoplasm metastasis (129) 129
therapy (128) 128
liver neoplasms - secondary (127) 127
endocrinology & metabolism (121) 121
article (120) 120
metastatic pheochromocytoma (119) 119
phase-ii trial (119) 119
metastatic (118) 118
breast-cancer (113) 113
renal-cell carcinoma (113) 113
antineoplastic combined chemotherapy protocols - therapeutic use (108) 108
endothelial growth-factor (106) 106
expression (105) 105
metastatic melanoma (104) 104
review (104) 104
melanoma (103) 103
patients (103) 103
positron-emission-tomography (103) 103
prostate cancer (103) 103
cell biology (101) 101
paraganglioma (98) 98
breast cancer (97) 97
metastatic neuroendocrine tumors (96) 96
gastroenterology & hepatology (94) 94
hematology, oncology and palliative medicine (94) 94
liver (91) 91
clinical trials (89) 89
angiogenesis (86) 86
development and progression (86) 86
disease-free survival (86) 86
adenocarcinoma (84) 84
mutation (84) 84
survival rate (84) 84
cancer therapies (83) 83
liver metastases (82) 82
phase-ii (81) 81
cancer research (79) 79
double-blind (78) 78
risk factors (78) 78
metastatic disease (77) 77
colorectal cancer (76) 76
medicine (76) 76
mice (75) 75
neoplasms (75) 75
phase-iii trial (75) 75
medical prognosis (74) 74
pheochromocytoma (74) 74
immunotherapy (73) 73
lung-cancer (73) 73
neoplasms - pathology (73) 73
survival analysis (73) 73
metastatic carcinoma (71) 71
disease progression (70) 70
usage (70) 70
drug therapy (69) 69
diagnosis, differential (68) 68
medical research (67) 67
pancreatic neoplasms - pathology (67) 67
prognostic-factors (67) 67
neoplasm staging (66) 66
solid tumors (66) 66
adolescent (65) 65
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1866) 1866
French (17) 17
German (12) 12
Japanese (6) 6
Korean (6) 6
Spanish (2) 2
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology Clinics of North America, ISSN 0889-8553, 09/2016, Volume 45, Issue 3, pp. 487 - 507
Neuroendocrine tumors are increasingly diagnosed, either incidentally as part of screening processes, or for symptoms, which have commonly been mistaken for... 
Therapy | Tumor | Carcinoid | Diagnostics | Multimodal | Neuroendocrine | METASTATIC CARCINOID-TUMORS | SOMATOSTATIN ANALOGS | PROGNOSTIC-FACTORS | LONG-TERM OUTCOMES | GASTROINTESTINAL-TRACT | HEPATIC ARTERIAL CHEMOEMBOLIZATION | CHROMOGRANIN-A | LIVER METASTASES | PHASE-II TRIAL | RECEPTOR RADIONUCLIDE THERAPY | GASTROENTEROLOGY & HEPATOLOGY | Pancreatic Neoplasms - metabolism | Pancreatic Neoplasms - diagnosis | Humans | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Liver Neoplasms - therapy | Neuroendocrine Tumors - diagnosis | Embolization, Therapeutic | Organometallic Compounds | Gastrointestinal Neoplasms - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Chromogranin A - metabolism | Receptors, Somatostatin - metabolism | Liver Neoplasms - secondary | Radiopharmaceuticals | Gastrointestinal Neoplasms - metabolism | Neuroendocrine Tumors - metabolism | Pancreatic Neoplasms - pathology | Hepatic Artery | Hydroxyindoleacetic Acid - metabolism | Gastrointestinal Neoplasms - diagnosis | Gastrointestinal Neoplasms - therapy | Octreotide - therapeutic use | Malignant Carcinoid Syndrome - therapy | Positron Emission Tomography Computed Tomography | Magnetic Resonance Imaging | Metastasectomy | Digestive System Surgical Procedures | Neuroendocrine Tumors - secondary | Serotonin - metabolism | Gallium Radioisotopes | Fluorodeoxyglucose F18 | Neuroendocrine Tumors - therapy | Neoplasm Staging | Pancreatic Neoplasms - therapy
Journal Article
Nature Medicine, ISSN 1078-8956, 06/2017, Volume 23, Issue 6, pp. 664 - 673
Neuroendocrine (NE) cancers are a diverse group of neoplasms typically diagnosed and treated on the basis of their site of origin. This Perspective focuses on... 
MOLECULAR CHARACTERIZATION | MEDICINE, RESEARCH & EXPERIMENTAL | PANCREATIC ENDOCRINE NEOPLASMS | TRANSGENIC MOUSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTIANDROGEN RESISTANCE | CONDITIONAL MOUSE MODEL | AURORA KINASE | METASTATIC PROSTATE-CANCER | T-ANTIGEN | CELL BIOLOGY | CELL LUNG-CANCER | N-MYC | Lung Neoplasms - drug therapy | Colonic Neoplasms - genetics | Carcinoma, Small Cell - genetics | Colonic Neoplasms - drug therapy | Epigenesis, Genetic | Humans | Male | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Tumor Suppressor Protein p53 - genetics | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Prostatic Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Female | Cell Differentiation | Retinoblastoma Binding Proteins - genetics | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Triazoles - therapeutic use | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Neuroendocrine - drug therapy | Carcinoma, Small Cell - drug therapy | Carcinogenesis - genetics | Head and Neck Neoplasms - drug therapy | Carcinoma, Neuroendocrine - genetics | Uterine Cervical Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Uterine Cervical Neoplasms - genetics | Disease Progression | Azepines - therapeutic use | Neuroendocrine Tumors - genetics | Proto-Oncogene Proteins c-met - genetics | Cell Lineage | Cell Plasticity - genetics | Esophageal Neoplasms - genetics | Pyrimidines - therapeutic use | Neuroendocrine Tumors - drug therapy | Head and Neck Neoplasms - genetics | Proto-Oncogene Proteins c-myc - genetics | Ubiquitin-Protein Ligases - genetics | Benzodiazepines - therapeutic use | Esophageal Neoplasms - drug therapy | Proteins | Research | Health aspects | Carcinogenesis | Gastrin
Journal Article
Annals of Surgery, ISSN 0003-4932, 05/2013, Volume 257, Issue 5, pp. 807 - 815
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 7, pp. 934 - 943
Journal Article
Endocrinology and Metabolism Clinics of North America, ISSN 0889-8529, 09/2018, Volume 47, Issue 3, pp. 603 - 614
Journal Article
Journal Article
Cancer and Metastasis Reviews, ISSN 0167-7659, 3/2014, Volume 33, Issue 1, pp. 353 - 359
Journal Article
Journal of Hepato‐Biliary‐Pancreatic Sciences, ISSN 1868-6974, 08/2015, Volume 22, Issue 8, pp. 578 - 585
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 50, Issue 5, pp. 902 - 911
Journal Article